RUNX1 and acute lymphoblastic leukemia: Recently, our group observed endogenous T-cell recognition of the ETV6::RUNX1 fusion neoantigen in patients with ALL, which is the most common genetic aberration in childhood ALL, occurring in approximately 25% of patients [15, 16].